Evidence map›Paper›PMID 38890799›Full record

ArticleExperimental physiology2024

Haemodynamic, hormonal and renal actions of osteocrin in normal sheep.

Nicola J A Scott, Timothy C R Prickett, Christopher J Charles, Eric A Espiner, A Mark Richards, Miriam T Rademaker

Abstract read
In one paragraph

Article in Experimental physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. C-type natriuretic peptide and collagen X marker are aberrant in skeletal dysplasias.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nicola J A ScottDepartment of Medicine, Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand.ORCID 0000-0002-5685-9151
Timothy C R PrickettDepartment of Medicine, Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand.
Christopher J CharlesDepartment of Medicine, Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand.
Eric A EspinerDepartment of Medicine, Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand.
A Mark RichardsDepartment of Medicine, Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand.
Miriam T RademakerDepartment of Medicine, Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand.

Funding

Heart Foundation of New Zealand #1889
6 · The paper itself

Abstract

Osteocrin (OSTN) is an endogenous protein sharing structural similarities with the natriuretic peptides [NPs; atrial (ANP), B-type (BNP) and C-type (CNP) NP], which are hormones known for their crucial role in maintaining pressure/volume homeostasis. Osteocrin competes with the NPs for binding to the receptor involved in their clearance (NPR-C). In the present study, having identified, for the first time, the major circulating form of OSTN in human and ovine plasma, we examined the integrated haemodynamic, endocrine and renal effects of vehicle-controlled incremental infusions of ovine proOSTN (83-133) and its metabolism in eight conscious normal sheep. Incremental i.v. doses of OSTN produced stepwise increases in circulating concentrations of the peptide, and its metabolic clearance rate was inversely proportional to the dose. Osteocrin increased plasma levels of ANP, BNP and CNP in a dose-dependent manner, together with concentrations of their intracellular second messenger, cGMP. Increases in plasma cGMP were associated with progressive reductions in arterial pressure and central venous pressure. Plasma cAMP, renin and aldosterone were unchanged. Despite significant increases in urinary cGMP levels, OSTN administration was not associated with natriuresis or diuresis in normal sheep. These results support OSTN as an endogenous ligand for NPR-C in regulating plasma concentrations of NPs and associated cGMP-mediated bioactivity. Collectively, our findings support a role for OSTN in maintaining cardiovascular homeostasis.

Indexed as

Cyclic GMPHemodynamicsKidneyAldosteroneAnimalsAtrial Natriuretic FactorBlood PressureCyclic AMPFemaleNatriuresisNatriuretic Peptide, BrainNatriuretic Peptide, C-TypeNatriuretic PeptidesReninSheepAldosteroneAtrial Natriuretic FactorCyclic AMPCyclic GMPNatriuretic Peptide, BrainNatriuretic Peptide, C-TypeNatriuretic PeptidesRenincAMPcGMPnatriuretic peptidesosteocrin metabolismosteocrin molecular forms

Identifiers

PMID38890799
PMCPMC11291853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.